Therapeutic impact of SGLT2 inhibitors following transcatheter aortic valve implantation: a grade-assessed systematic review and meta-analysis.
European Journal of Clinical Pharmacology · 2026
DOI: 10.1007/s00228-026-04064-0 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Clinical Pharmacology, 2026. Verfasst von Khadeeja Ali Hamzah und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, ALkindy college of medicine, University of Baghdad, Baghdad, Iraq. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Sodium-Glucose Transporter 2 Inhibitors, Aortic Valve Stenosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: We aim to evaluate the impact of sodium-glucose cotransporter-2 (SGLT2) inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI). METHODS: We conducted a PRISMA-guided systematic review and meta-analysis of studies comparing SGLT2 inhibitor therapy with standard care in adults undergoing TAVI. PubMed, Embase, Scopus, Web of Science, and Cochrane Library were searched from inception to November 2025. Outcomes included all-cause mortality, heart failure (HF) hospitalization, myocardial infarction (MI), cardiac death, stroke, pacemaker implantation, acute kidney injury (AKI), and bleeding events. Effect sizes were pooled using random-effects models, while time-to-event data were reconstructed for survival analyses. RESULTS: Four studies comprising 12,374 patients were included. SGLT2 inhibitor therapy significantly reduced all-cause mortality (RR 0.62, 95% CI 0.49–0.78), HF hospitalization (RR 0.67, 95% CI 0.50–0.91), MI (RR 0.83, 95% CI 0.73–0.93), and bleeding events (RR 0.81, 95% CI 0.72–0.90). Effects on cardiac death, stroke, pacemaker implantation, and AKI were not statistically significant (P > 0.05). CONCLUSION: SGLT2 inhibitor therapy in patients undergoing TAVI was associated with reductions in all-cause mortality, HF hospitalization, and MI. However, these findings are based on a limited and heterogeneous evidence base, largely derived from observational studies, and should be interpreted with caution. The results should not be considered definitive or generalizable to all TAVI populations. Further adequately powered randomized trials are required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, ALkindy college of medicine, University of Baghdad, Baghdad, Iraq.
- Department of Internal Medicine, College of Medicine, University of Kufa, Najaf, Iraq.
- Department of Internal Medicine, College of Medicine, University of Baghdad, 502, Filastin St, Baghdad, Iraq. allawy1234@gmail.com.
- Department of Cardiology, Camden Clark Medical Center, West Virginia University, Parkersburg, WV, USA. allawy1234@gmail.com.
- Department of Internal Medicine, College of Medicine, University of Baghdad, 502, Filastin St, Baghdad, Iraq.
- Department of Internal Medicine, King Edward Medical University, Lahore, Pakistan.
Zitieren
APA
Hamzah, K. A., Kurmasha, Y. H., Al-Shammari, A. S., Shweliya, M. A., Al-Janabi, A. A. H., Shahzaib, M., Akoum, A., & Sattar, Y. (2026). Therapeutic impact of SGLT2 inhibitors following transcatheter aortic valve implantation: a grade-assessed systematic review and meta-analysis. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-026-04064-0
Vancouver
Hamzah KA, Kurmasha YH, Al-Shammari AS, Shweliya MA, Al-Janabi AAH, Shahzaib M, et al. Therapeutic impact of SGLT2 inhibitors following transcatheter aortic valve implantation: a grade-assessed systematic review and meta-analysis. European Journal of Clinical Pharmacology. 2026. doi:10.1007/s00228-026-04064-0
BibTeX
@article{Hamzah2026,
author = {Hamzah, Khadeeja Ali and Kurmasha, Yousif Hameed and Al-Shammari, Ali Saad and Shweliya, Mohammedsadeq A and Al-Janabi, Ali Alsajad Hussein and Shahzaib, Muhammad and Akoum, Atef and Sattar, Yasar},
title = {Therapeutic impact of SGLT2 inhibitors following transcatheter aortic valve implantation: a grade-assessed systematic review and meta-analysis},
journal = {European Journal of Clinical Pharmacology},
year = {2026},
doi = {10.1007/s00228-026-04064-0}
}
EUVIMED